Table 1.
Allele
|
MAF
|
OR |
P
|
||||||
---|---|---|---|---|---|---|---|---|---|
Risk | Minor | Cases | Controls | HW | Observed | Adjusted | Empirical | ||
GeneQuest CAD (N = 381) and control (N = 560) | |||||||||
rs7546246 | C | C | 0.461 | 0.399 | 1.29 | 0.38 | 0.011 | 0.002 | 0.012 |
rs2297660 | A | A | 0.446 | 0.386 | 1.28 | 0.47 | 0.014 | 0.007 | 0.017 |
rs3737983 | T | T | 0.474 | 0.402 | 1.34 | 0.14 | 0.003 | 0.001 | 0.003 |
rs5177 | G | G | 0.436 | 0.389 | 1.22 | 0.19 | 0.047 | 0.012 | 0.049 |
GeneQuest MI (N = 183) and control (N = 560) | |||||||||
rs7546246 | C | C | 0.470 | 0.399 | 1.33 | 0.38 | 0.018 | 0.003 | 0.019 |
rs2297660 | A | A | 0.467 | 0.386 | 1.40 | 0.47 | 0.006 | 0.008 | 0.007 |
rs3737983 | T | T | 0.486 | 0.402 | 1.41 | 0.14 | 0.005 | 0.003 | 0.005 |
rs5177 | G | G | 0.449 | 0.389 | 1.28 | 0.19 | 0.029 | 0.012 | 0.033 |
Italian MI (N = 248) and control (N = 308) | |||||||||
rs7546246 | C | C | 0.424 | 0.338 | 1.44 | 0.36 | 0.004 | 0.007 | 0.005 |
rs2297660 | A | A | 0.439 | 0.331 | 1.58 | 0.53 | 3.0 × 10−4 | 8.0 × 10−4 | 3.0 × 10−4 |
rs3737983 | T | T | 0.416 | 0.350 | 1.32 | 0.64 | 0.027 | 0.009 | 0.030 |
rs5177 | G | G | 0.421 | 0.347 | 1.37 | 0.29 | 0.012 | 0.008 | 0.015 |
Combined (CAD/MI = 629; control = 868) | |||||||||
rs7546246 | C | C | 0.445 | 0.378 | 1.32 | 0.46 | 3.0 × 10−4 | 8.0 × 10−4 | 7.0 × 10−4 |
rs2297660 | A | A | 0.446 | 0.367 | 1.39 | 0.21 | 2.0 × 10−5 | 1.0 × 10−4 | 2.0 × 10−4 |
rs3737983 | T | T | 0.449 | 0.384 | 1.31 | 0.15 | 4.0 × 10−4 | 1.0 × 10−4 | 5.0 × 10−4 |
rs5177 | G | G | 0.432 | 0.374 | 1.27 | 0.15 | 0.002 | 0.003 | 0.002 |
MAF: minor allele frequency; OR: odds ratio; P-HW: P-value for Hardy–Weinberg disequilibrium analysis; P-observed: uncorrected P-value; P-adjusted: P-value obtained after adjustment for gender, age, hypertension, diabetes and plasma total cholesterol levels; P-empirical: permutation P-value calculated using 10,000 Monte Carlo simulations.